No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
NVCR Novocure
- 23.700
- +0.950+4.18%
Close May 22 16:00 ET
2.55BMarket Cap-13093P/E (TTM)
23.870High22.600Low1.43MVolume22.600Open22.750Pre Close33.59MTurnover1.46%Turnover RatioLossP/E (Static)107.61MShares82.64052wk High7.10P/B2.32BFloat Cap10.87052wk Low--Dividend TTM98.03MShs Float232.760Historical High--Div YieldTTM5.58%Amplitude5.950Historical Low23.556Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Monday.Shares of Overseas Shipholding Group, Inc. (NYSE:OSG) rose sharply during Monday's session after the company anno
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.
Unveiling 8 Analyst Insights On NovoCure
Throughout the last three months, 8 analysts have evaluated NovoCure (NASDAQ:NVCR), offering a diverse set of opinions from bullish to bearish.The following table summarizes their recent ratings, shed
Earnings Call Summary | Novocure(NVCR.US) Q1 2024 Earnings Conference
The following is a summary of the NovoCure Limited (NVCR) Q1 2024 Earnings Call Transcript:Financial Performance:NovoCure reported a net revenue of $139 million in Q1 2024, up 13% year-over-year. The
Novocure Is Maintained at Neutral by HC Wainwright & Co.
Novocure Is Maintained at Neutral by HC Wainwright & Co.
NovoCure Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 70.54% HC Wainwright & Co. $24 → $22 Maintains Neutral 04/10/2024 117.05% Piper Sandler $25 → $
Comments
$Novocure(NVCR.US$ pt anyone?
2
$Novocure(NVCR.US$ I placed limit buy @13.1 but got filled at 13.299, I noticed this many times in this app, they are causing slippage, anyone noticed same?
1
$iBio Inc (IBIO.US)$ IBIO: 119% | IBio shares are trading higher after the company collaborated with AstralBio for AI drug-powered antibodies for obesity and cardiometabolic diseases.
DRCT: -49% | Direct Digital Holdings shares are trading lower after the company reported worse-than-expected Q4 financial results.
NVCR: 42% | Novocure shares are trading higher after the company's METIS Phase 3 trial met primary endpoint, demonstrating statistically significant extension in time to intracranial ...
DRCT: -49% | Direct Digital Holdings shares are trading lower after the company reported worse-than-expected Q4 financial results.
NVCR: 42% | Novocure shares are trading higher after the company's METIS Phase 3 trial met primary endpoint, demonstrating statistically significant extension in time to intracranial ...
Morning Movers
Gapping up
$Deutsche Bank(DB.US$ shares rose 3% after Morgan Stanley upgraded the stock to overweight, suggesting further potential growth following a strong performance in 2024.
$Merck & Co(MRK.US$ stock rose 4.8% after its drug for treating a rare lung disease received FDA approval.
$Trump Media & Technology(DJT.US$ stock jumped 14%, following gains after its Nasdaq debut.
$Robinhood(HOOD.US$ stock climbed 6...
Gapping up
$Deutsche Bank(DB.US$ shares rose 3% after Morgan Stanley upgraded the stock to overweight, suggesting further potential growth following a strong performance in 2024.
$Merck & Co(MRK.US$ stock rose 4.8% after its drug for treating a rare lung disease received FDA approval.
$Trump Media & Technology(DJT.US$ stock jumped 14%, following gains after its Nasdaq debut.
$Robinhood(HOOD.US$ stock climbed 6...
33
Key Takeaway
GameStop ( $GameStop(GME.US$ ) and Forge Global ( $Forge Global(FRGE.US$ ) face pre-market declines of 17% and 11% respectively, while Novocure ( $Novocure(NVCR.US$ ) surges 30% on positive trial results.
Merck ( $Merck & Co(MRK.US$ ) gains 4% after FDA approval of its treatment, highlighting a day of significant volatility and strategic moves in the U.S. stock market.
A Glimpse into Quarter-End Moves
As the curtains draw near on...
GameStop ( $GameStop(GME.US$ ) and Forge Global ( $Forge Global(FRGE.US$ ) face pre-market declines of 17% and 11% respectively, while Novocure ( $Novocure(NVCR.US$ ) surges 30% on positive trial results.
Merck ( $Merck & Co(MRK.US$ ) gains 4% after FDA approval of its treatment, highlighting a day of significant volatility and strategic moves in the U.S. stock market.
A Glimpse into Quarter-End Moves
As the curtains draw near on...
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
灵巧的托拜厄斯 : 有
Kenneil NugentOP : lol no help